title: The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation.
abstract: Hepatitis C virus (HCV) infection is the leading cause of liver transplantation (LT) in Western countries. Polymorphism in the IL28B gene region has a major impact on the natural history and response to antiviral treatment in HCV. We investigated whether IL28B polymorphism was associated with graft survival in patients with or without HCV undergoing LT. 1,060 adult patients (age >18 years) underwent LT between years 2000 and 2008. Patients with previous LT, living donor LT and patients dying or requiring retransplants within 30 days of LT were excluded. DNA samples of 620 (84%) recipients and 377 (51%) donors were available for genotyping of IL28B rs12979860C>T. Donor IL28B genotypes had no significant differences in graft survival irrespective of HCV status. There was no difference in graft outcome in the non-HCV cohort (n = 293) based on recipient IL28B genotype. In the HCV group (n = 327), recipients with CC or CT genotype had better graft survival compared to TT genotype (62% vs. 48%, p = 0.02). HCV recipients with CC or CT genotype had delayed time to clinically relevant HCV recurrence compared to TT (10.4 vs. 6.7 months, p = 0.002). The beneficial effect of the CC/CT genotype on HCV recurrence and graft survival was independent of antiviral treatment. In conclusion, our study demonstrated that in contrast to donor IL28B genotype recipient IL28B was associated with graft survival and clinically relevant HCV recurrence in HCV infected recipients. No effect of IL28B genotype was manifest in non-HCV LT recipients.
authors: Division of Nephrology, Mount Sinai School of Medicine, New York, New York, USA.
authors: Sridhar R
authors: SR
authors: Allam
authors: Bernd
authors: B
authors: Krüger
authors: Anita
authors: A
authors: Mehrotra
authors: Thomas
authors: T
authors: Schiano
authors: Bernd
authors: B
authors: Schröppel
authors: Barbara
authors: B
authors: Murphy
mesh_terms: D005260:Female; D015870:Gene Expression; D005838:Genotype; D006085:Graft Survival / Q000235:genetics* / Q000276:immunology; D006526:Hepatitis C / Q000150:complications* / Q000401:mortality / Q000821:virology; D006801:Humans; D007372:Interferons; D007378:Interleukins / Q000235:genetics*; D008103:Liver Cirrhosis / Q000209:etiology / Q000628:therapy*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D012008:Recurrence; D013997:Time Factors; D000095022:Interferon Lambda
chemical_list: D007372:Interferons; D007378:Interleukins; C000624353:interferon-lambda, human; D000095022:Interferon Lambda
references: Blood. 2009 Jun 4;113(23):5868-77
references: 19304955
references: J Hepatol. 2011 Aug;55(2):289-98
references: 21147189
references: Nature. 2009 Sep 17;461(7262):399-401
references: 19684573
references: J Hepatol. 2011 Aug;55(2):322-7
references: 21147186
references: Transplantation. 2012 Jul 27;94(2):197-203
references: 22766768
references: Hepatology. 2011 Jan;53(1):317-24
references: 21254179
references: Transplant Proc. 2007 Jun;39(5):1477-80
references: 17580166
references: Transplantation. 2012 Aug 15;94(3):275-80
references: 22790387
references: Pharmacogenomics. 2009 Nov;10(11):1819-37
references: 19891557
references: Gastroenterology. 2010 Nov;139(5):1577-85, 1585.e1-3
references: 20708617
references: Nature. 2009 Oct 8;461(7265):798-801
references: 19759533
references: Am J Transplant. 2008 Nov;8(11):2426-33
references: 18727694
references: Nat Genet. 2009 Oct;41(10):1105-9
references: 19749757
references: Hepatology. 1994 Jun;19(6):1513-20
references: 8188183
references: Liver Transpl. 2007 May;13(5):719-24
references: 17457933
references: Gastroenterology. 2010 Aug;139(2):499-509
references: 20434452
references: Liver Transpl. 2011 Mar;17(3):289-98
references: 21384511
references: Lab Invest. 2004 Sep;84(9):1148-59
references: 15208644
references: Am J Transplant. 2011 May;11(5):1051-7
references: 21466653
references: Blood. 2007 Dec 1;110(12):4077-85
references: 17690256
references: Am J Epidemiol. 2009 Feb 15;169(4):505-14
references: 19126586
references: Ann Surg. 2001 Sep;234(3):384-93; discussion 393-4
references: 11524591
references: Gastroenterology. 2010 Oct;139(4):1422-4
references: 20800110
references: Gastroenterology. 2010 Nov;139(5):1586-92, 1592.e1
references: 20637200
references: PLoS One. 2009;4(3):e4933
references: 19300512
references: Ann Intern Med. 2006 May 16;144(10):705-14
references: 16702586
references: Gastroenterology. 2010 Apr;138(4):1338-45, 1345.e1-7
references: 20060832
references: Hepatology. 2010 Dec;52(6):1888-96
references: 20931559
references: J Hepatol. 2012 Feb;56(2):355-8
references: 21889467
references: Nat Immunol. 2003 Jan;4(1):63-8
references: 12469119